List clinical trials by disease
Search Clinical Trials
The results of your search are listed below. To view the details of a trial or study, click on the link. Or start a new search.
Searched for: Prostate Cancer. 12 results shown below.
SCORE -- Assessment of Mood, Information Processing and Quality of Life in Prostate Cancer Survivors and Patients
Monique Cherrier, PhD
30824
NA
Intermittent Chemotherapy With or Without GM-CSF for Metastatic HPRC
[Complete title: A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy with Maintenance GM-CSF in Patients with Previously Untreated Metastatic Hormone Refractory Prostate Cancer]
Tia Higano, MD
6620
II
Molecular Correlates of Sensitivity and Resistance to Therapy in Prostate Cancer
[Complete title: Molecular correlates of sensitivity and resistance to therapy in prostate cancer]
Robert Montgomery, MD
6932
NA
Phenelzine Sulfate and Docetaxel for Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel
[Complete title: A Phase II Study of MAOA Inhibitor Plus Docetaxel in Patients Currently Receiving and Progressing on Docetaxel Therapy]
Evan Yu, MD
7563
II
Abiraterone Acetate in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
[Complete title: Open Label Pharmacodynamic Study of Abiraterone in the Treatment of Metastatic, Castration Resistant Prostate Cancer]
Robert Montgomery, MD
7639
II
Cabozantinib in Treating Men With Hormone-Resistant Prostate Cancer
[Complete title: A Pilot Study of the Effects of Cabozantinib (XL184) on Bone Turnover and Microenvironment in Men With Non-Metastatic and Metastatic Castration-Resistant Prostate Cancer]
Tia Higano, MD
7819
Pilot
Abiraterone Acetate and Prednisone With or Without Veliparib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
[Complete title: A Randomized Gene Fusion Stratified Phase 2 Trial Of Abiraterone With Or Without ABT-888 For Patients With Metastatic Castration-Resistant Prostate Cancer]
Robert Montgomery, MD
7847
II
A Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
George Laramore, MD, PhD
6864
III
Study of MLN8237 in Patients With Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel/Prednisone Regimen
[Complete title: A Randomized Phase 2 Study of MLN8237, an Aurora A Kinase Inhibitor, or No MLN8237 in Patients with Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel/Prednisone Regimen, Preceded by a Phase I Dose-Escalation Study - Part 1 and 2]
Tia Higano, MD
20100481
II
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer
[Complete title: A Phase 1, Open-Label Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP30862 in Patients with Metastatic Castration-Resistant Prostate Cancer]
Tia Higano, MD
20121064
I
A Study of Alpharadin® With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)
[Complete title: A PhaseI/IIa Study of Safety and Efficacy of Alpharadin® with Docetaxel in Patients with Bone Metastases from Castration-Resistant Prostate Cancer]
Tia Higano, MD
20121484
I/II
Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer
[Complete title: Phase II, open label study of the effect of GTx-758 as secondary hormonal therapy on serum PSA and serum free testosterone levels in men with metastatic castration resistant prostate cancer maintained on androgen deprivation therapy.]
Evan Yu, MD
20122140
II
Search Options
OR
OR
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
- Talk to your health care providers first before making decisions about your health care.
- Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.
